LncRNA KCNQ1OT1靶向miR-324-5p对急性髓系白血病细胞恶性生物学行为的影响

doi:10.3969/j.issn.1006-6233.2025.03.01

Abstract
Figure/Table
References
Related Citation (10)

Download: PDF (2701 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To investigate the effect of long non-coding RNA (LncRNA) KCNQ1 opposite strand/antisense transcript 1 (KCNQ1OT1) on the malignant biological behavior of acute myeloid leukemia (AML) cells by targeting miR-324-5p. Methods: The expression levels of LncRNA KCNQ1OT1 and miR-324-5p in human bone marrow stromal cells (HS-5) and AML cell lines (U937, MOLM-13, HL-60) were detected using quantitative real-time PCR (qPCR). RNA immunoprecipitation (RIP), RNA pull-down, and dual-luciferase reporter assays were performed to validate the targeting relationship between LncRNA KCNQ1OT1 and miR-324-5p in U937 cells. U937 cells were divided into five groups: control group, si-KCNQ1OT1 group, miR-324-5p mimics group, si-NC+miR-324-5p-NC group, and si-KCNQ1OT1+miR-324-5p inhibitor group. Cells were transfected with LncRNA KCNQ1OT1 siRNA, miR-324-5p mimics, or corresponding controls. The expression of LncRNA KCNQ1OT1 and miR-324-5p was measured by qPCR. Cell proliferation was assessed using Edu staining, cell invasion and migration were evaluated by Transwell assays, apoptosis was detected by flow cytometry, mitochondrial membrane potential was measured using JC-1 fluorescence staining, and the expression of proliferation-, apoptosis-, and epithelial-mesenchymal transition (EMT)-related proteins was analyzed by Western blot. Results: LncRNA KCNQ1OT1 specifically bound to miR-324-5p in U937 cells. Compared to the control group, the si-KCNQ1OT1 and miR-324-5p mimics groups showed significantly higher miR-324-5p expression (2.21±0.20, 2.30±0.19 vs 0.98±0.13) and apoptosis rates (49.63±2.15%, 54.92±2.67% vs 1.87±0.61%) (P<0.05), while Edu positivity rates (24.14±5.72%, 17.65±4.16% vs 73.52±8.29%), invasion counts (96.83±15.75, 83.50±16.28 vs 327.00±24.56), migration counts (115.33±18.67, 103.50±20.13 vs 383.50±29.25), and mitochondrial membrane potential (0.73±0.21, 0.56±0.18 vs 5.92±0.49) were significantly lower (P<0.05). In the si-KCNQ1OT1+miR-324-5p inhibitor group, miR-324-5p expression (1.02±0.14 vs 2.21±0.20) and apoptosis rates (3.02±0.94% vs 49.63±2.15%) were lower than in the si-KCNQ1OT1 group (P<0.05), while Edu positivity rates (68.93±8.35% vs 24.14±5.72%), invasion counts (309.50±21.90 vs 96.83±15.75), migration counts (368.33±26.40 vs 115.33±18.67), and mitochondrial membrane potential (5.65±0.51 vs 0.73±0.21) were higher (P<0.05). Statistical values were as follows: miR-324-5p expression (F=100.155, P=0.000), apoptosis rate (F=1708.438, P=0.000), Edu positivity rate (F=90.177, P=0.000), invasion count (F=217.555, P=0.000), migration count (F=219.404, P=0.000), and mitochondrial membrane potential (F=311.520, P=0.000). Conclusion: Silencing LncRNA KCNQ1OT1 attenuates the malignant biological behavior of AML cells by upregulating miR-324-5p.

Key words： LncRNA KCNQ1OT1 miR-324-5p Acute myeloid leukemia Malignant biological behavior

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WEI Qingcheng
	LUO Peichun
	LI Huizhen
	et al

Cite this article:

WEI Qingcheng,LUO Peichun,LI Huizhen, et al. Effect of LncRNA KCNQ1OT1 Targeting miR-324-5p on the Malignant Biological Behavior of Acute Myeloid Leukemia Cells[J]. HeBei Med, 2025, 31(3): 353-361.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2025.03.01 OR http://www.hbyxzzs.cn/EN/Y2025/V31/I3/353

[1] Wachter F,Pikman Y.Pathophysiology of acute myeloid leukemia[J].Acta Haematol,2024,147(2):229-246.
[2] Becker M,Farina K A,Mascarenhas J.Acute myeloid leukemia:current understanding and management[J].JAAPA,2024,37(1):34-39.
[3] Cagle P,Qi Q,Niture S,et al.KCNQ1OT1:an oncogenic long noncoding RNA[J].Biomolecules,2021,11(11):1602-1618.
[4] Wen J,Ding Y,Zheng S,et al.Sevoflurane suppresses glioma cell proliferation,migration,and invasion both in vitro and in vivo partially via regulating KCNQ1OT1/miR-146b-5p/STC1 axis[J].Cancer Biother Radiopharm,2024,39(2):105-116.
[5] Wang Y,Jiang X Y,Qu M Y,et al.LncRNA KCNQ1OT1/miR-496/HMGB1 signaling axis promotes invasion and migration of non-small cell lung cancer cells[J].Biochem Genet,2024,62(3):1994-2009.
[6] Cheng P,Lu P,Guan J,et al.LncRNA KCNQ1OT1 controls cell proliferation,differentiation and apoptosis by sponging miR-326 to regulate c-Myc expression in acute myeloid leukemia[J].Neoplasma,2020,67(2):238-248.
[7] Gunel N S,Birden N,Kurt C C,et al.Effect of valproic acid on miRNAs affecting histone deacetylase in a model of anaplastic thyroid cancer[J].Mol Biol Rep,2021,48(8):6085-6091.
[8] Zhang C,Lv H,Zhang F,et al.LncRNA HCG18 facilitates melanoma progression by modulating miR-324-5p/CDK16 axis[J].Am Transl Res,2022,14(2):1246-1257.
[9] Misir S,Ozer Yaman S,Petrovic N,et al.Identification of a novel hsa_circ_0058058/miR-324-5p axis and prognostic/predictive molecules for acute myeloid leukemia outcome by bioinformatics-based analysis[J].Biology (Basel),2024,13(7):487-505.
[10] Yang Q,Fu J,Wang M,et al.MiR-1299 is regulated by KCNQ1OT1 and inhibits cervical cancer progression[J].Cell Mol Biol (Noisy-le-grand),2023,69(10):166-173.
[11] Liu G,Shi L,Wang B,et al.Role of oncogenic long noncoding RNA KCNQ1OT1 in colon cancer[J].Oncol Res,2024,32(3):585-596.
[12] Tang D,Luo Y,Jiang Y,et al.LncRNA KCNQ1OT1 activated by c-Myc promotes cell proliferation via interacting with FUS to stabilize MAP3K1 in acute promyelocytic leukemia[J].Cell Death Dis,2021,12(9):795-804.
[13] Kang H S,Park H Y,Lim H,et al.Different miRNAs related to FBXW7 mutations or high mitotic indices contribute to rectal neuroendocrine tumors:a pilot study[J].Int Mol Sci.2023,24(7):6329-6341.
[14] Wu B,Wang F,Wang Y,et al.CircATIC contributes to multiple myeloma progression via miR-324-5p-dependent regulation of HGF[J].Biochem Genet,2022,60(6):2515-2532.
[15] Wang P,Wang T,Dong L,et al.Circular RNA circ_0079593 facilitates glioma development via modulating miR-324-5p/XBP1 axis[J].Metab Brain Dis,2022,37(7):2389-2403.